“…Similarly, it can be beneficial in neurodevelopmental and neurodegenerative conditions, where clinical phenotypes are diverse and can be influenced by medication interactions and disease progression. These conditions include ASD and ADHD [ 9 – 11 , 15 , 23 , 27 ] schizophrenia [ 28 , 29 ], Parkinson's disease [ 13 , 30 – 32 ], and Alzheimer's disease [ 33 – 35 ]. The variability and complexity of these disorders make traditional classification challenging, highlighting the need for advanced techniques such as machine learning to improve diagnosis and understanding.…”